GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sernova Corp (XTER:PSH) » Definitions » Pretax Margin %

Sernova (XTER:PSH) Pretax Margin % : % (As of Jan. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sernova Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Sernova's Pre-Tax Income for the three months ended in Jan. 2024 was C$-9.74 Mil. Sernova's Revenue for the three months ended in Jan. 2024 was C$0.00 Mil. Therefore, Sernova's pretax margin for the quarter that ended in Jan. 2024 was %.

The historical rank and industry rank for Sernova's Pretax Margin % or its related term are showing as below:


XTER:PSH's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -176.72
* Ranked among companies with meaningful Pretax Margin % only.

Sernova Pretax Margin % Historical Data

The historical data trend for Sernova's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sernova Pretax Margin % Chart

Sernova Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Sernova Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Sernova's Pretax Margin %

For the Biotechnology subindustry, Sernova's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sernova's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sernova's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Sernova's Pretax Margin % falls into.



Sernova Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Sernova's Pretax Margin for the fiscal year that ended in Oct. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Oct. 2023 )/Revenue (A: Oct. 2023 )
=-38.998/0
= %

Sernova's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-9.743/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sernova  (XTER:PSH) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Sernova Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Sernova's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Sernova (XTER:PSH) Business Description

Traded in Other Exchanges
Address
700 Collip Circle, The Stiller Centre, Suite 114, London, ON, CAN, N6G 4X8
Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device designed to create a vascularized tissue environment for the transplantation and engraftment of therapeutic cells, which then release proteins and or hormones for the long-term treatment of multiple serious, chronic diseases such as diabetes, hemophilia, and thyroid disease.

Sernova (XTER:PSH) Headlines